Oaktree Acquisition Corp. III Life Sciences (OACC) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 Los Angeles, CA, 미국. 현재 CEO는 Mathew Pendo.
OACC 을(를) 보유 IPO 날짜 2024-12-16, 3 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $262.54M.
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
